| 中文名 | 5'-脱氧-5-氟-N-[(戊氧基)羰基]胞苷 2',3'-二乙酸酯 |
|---|---|
| 英文名 | 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate |
| 中文别名 |
(2Β,3Α,5Α,16Β,17Β)-2-(4-吗啉基)-16-(1-吡咯烷基)-雄甾烷-3,17-二醇
5'-脱氧-5-氟-N-[(戊氧基)羰基]胞苷 2',3'-二乙酸酯(卡培他滨中间体) 卡培他滨的中间体 2',3'-二-O-乙酰基-5'-脱氧-5-氟-N-(戊氧基羰基)胞苷 2',3'-二-O-乙酰基-5'-脱氧-5-氟-N 4 - (戊氧基羰基) - 组氨酸 (2R,3R,4R,5R)-2-(5-氟-2-氧代-4-(((戊氧基)羰基)氨基)嘧啶-1(2H)-基)-5-甲基四氢呋喃-3,4-二基二乙酸酯 3'-二乙酸酯 2',3'-二-O-乙酰基-5'-脱氧-5-氟-N4-正戊氧羰基胞苷 5-脱氧-2,3-二-O-乙酰基-N4【(正戊氧基)羰基】-5-氟胞苷 5'-脱氧-5-氟-N-[(戊氧基)羰基]胞嘧啶核苷-2',3'-二乙酸酯 2,3-二-O-乙酰卡培他滨 脱氧-5-氟-N-[(戊氧基)羰基]胞苷 2',3'-二乙酸酯(卡培他滨中间体 5'-脱氧-5-氟-N-[(戊 5'-脱氧-5-氟-N-[(戊氧基)羰基]胞嘧啶2',3'-二醋酸盐 2',3'-二-O-乙酰基-5'-脱氧-5-氟-N4-(戊氧羧基)胞苷 5′-脱氧-5-氟-N-[(戊氧基)羰基]胞苷2′,3′-二乙酸脂 卡培他滨中间体Cap-6 5'-脱氧-2',3'-二-O-乙酰基-N4-[(正戊氧基)羰基]-5-氟胞苷 卡培他滨杂质7(卡培他滨杂质G) 卡培他宾中间体3/5'-脱氧-5-氟-N-[(戊氧基)羰基]胞苷 2',3'-二乙酸酯 卡培他滨中间体1 5-脱氧-5-氟-N-[(戊氧基)羰基]胞苷2 卡培他滨杂质G 2',3'-二-O-乙酰基-5'-脱氧-5-氟-N4-(戊氧酰基)胞苷 5'-脱氧-2',3'-二-O-乙酰基-N4-[(二正戊氧基)羰基]-5-氟胞苷 卡培他滨中间体3 5-溴-4-氯-3-吲哚-Α-D-N-乙酰神经氨酸钠盐 卡培他滨中间体-A-09 卡培他宾中间体,5'-脱氧-5-氟-N-[(戊氧基)羰基]胞苷 2',3'-二乙酸酯 (2R,3R,4R,5R)-2-(5-氟-2-氧代-4-(((戊基氧基)羰基)氨基)嘧啶-1-(2H)-基)-5-甲基四氢呋喃-3,4-二基二乙酸酯 卡培他滨杂质J 卡六) |
| 英文别名 |
Capecitabine Intermediate-3
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate carbonyl]cytidine 2',3'-diacetate Capecitabine interMediate Pentyl [1-(2,3-Di-O-acetyl-5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]ca Pentyl [1-(2,3-Di-O-acetyl-5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]cbamate 5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetate Capecitabine Impurity 7(Capecitabine Impurity G) ICytidine,5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-Di-O-acetylcapecitabine Capecitabine Impurity 7 5'- deoxy -5- fluoro -N-[ (pentoxy) carbonyl] cytidine 2',3'- diacetate Capecitabine 2',3'-diacetate [1-(2,3-Di-O-acetyl-5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyriMidinyl]cbaMic Acid Pentyl Ester 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycboxyl)cytidine dihydro-2-oxo-4-pyrimidinyl]-, pentylester 5'-Deoxy-5-fluoro-N-[(pentyloxy) 5'-deoxy-5-fluore-N-[(pentyloxy) carbonyl] cytidine 2',3'-diacetate Capecitabine Impurity 2 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diac 5''-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2'',3''-diacetate Capecitabine Intermediate 1 T6NVNJ DMVO5 EF A- BT5OTJ COV1 DOV1 E1 &&Ribo-β-D Form 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-(pentyloxycbonyl)cytidine 5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate 5'-deoxi-5-fluoro-N-(pentyloxy)carbonyl cytidine-2',3'- diacetate Capecitabine Impurity G uoro-N-[(pentyL [(2R,3R,4R,5R)-4-acetyloxy-5-[5-fluoro-2-oxo-4-(pentoxycarbonylamino)pyrimidin-1-yl]-2-methyloxolan-3-yl] acetate 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycbonxyl)cytidine Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 2', 3'-Di-O-acetyl-5'-Deoxy-5-Fuluro-N4-(Pentoxycbonxyl)-Cytidine 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-(pentoxycboxyl)cytidine 5'Deoxy5fluoroN[(pentyloxy)carbonyl]cytidine 2',3'diacetate,5' Deoxy 5 fluoro N [(pentyloxy)carbonyl]cytidine 2',3' diacetate ]cytidine 2',3'-diacetate Capecitabine impurity J 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 5'-Deoxy-5-fL 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 5' Capecitabine-7 Cytidine,5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate Capecitabin iMpurity J (2R,3R,4R,5R)-2-(5-fluoro-2-oxo-4-(((pentyloxy)carbonyl)amino)pyriMidin-1(2H)-yl)-5-Methyltetrahydrofuran-3,4-diyl diacetate 2', 3'-Di-O-acetyl-5'-Deoxy-5-F-N4-(Pentoxycbonxyl)-Cytidine |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 熔点 | 111 °C |
| 分子式 | C19H26FN3O8 |
| 分子量 | 443.423 |
| 精确质量 | 443.170380 |
| PSA | 135.05000 |
| LogP | 2.14 |
| 外观性状 | 固体;White to Almost white powder to crystal |
| 折射率 | 1.567 |
| 储存条件 | 0-10°C;存放于惰性气体之中;避免空气,加热 |
| 水溶解性 | 可溶于:甲醇 |
| 危害码 (欧洲) | Xi |
|---|---|
| 海关编码 | 2934999090 |
|
~28%
162204-20-8 |
| 文献:Coll Farma S.L. Patent: EP2241556 A1, 2010 ; Location in patent: Page/Page column 9 ; |
|
~%
162204-20-8 |
| 文献:Shimma, Nobuo; Umeda, Isao; Arasaki, Motohiro; Murasaki, Chikako; Masubuchi, Kazunao; Kohchi, Yasunori; Miwa, Masanori; Ura, Masako; Sawada, Noriaki; Tahara, Hitoshi; Kuruma, Isamu; Horii, Ikuo; Ishitsuka, Hideo Bioorganic and Medicinal Chemistry, 2000 , vol. 8, # 7 p. 1697 - 1706 |
|
~%
162204-20-8 |
| 文献:Organic Letters, , vol. 14, # 13 p. 3348 - 3351 |
|
~%
162204-20-8 |
| 文献:Organic Letters, , vol. 14, # 13 p. 3348 - 3351 |
|
~%
162204-20-8 |
| 文献:Organic Letters, , vol. 14, # 13 p. 3348 - 3351 |
|
~%
162204-20-8 |
| 文献:Bioorganic and Medicinal Chemistry, , vol. 8, # 7 p. 1697 - 1706 |
| 上游产品 6 | |
|---|---|
| 下游产品 1 | |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |